Total public drug program spending in Canada by therapy 2022
This statistic displays the total public drug program expenditure in Canada by broad therapeutic category in 2022. In that year, total drug program spending dedicated to antineoplastic and immunomodulating agents totaled some 4.01 billion Canadian dollars.